News
A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a therapy for Alzheimer’s disease.
My name is Rohan Desai, and I am a third-year undergraduate student currently working in the lab Maj-Linda Selenica, PhD, to study the effects of TDP-43 proteinopathy in the multi-etiology of the Alzheimer’s Disease (AD), LATE, and FTD spectrum.
Anika Hartz, PhD, was recently promoted to professor in the UK College of Medicine Department of Pharmacology and Nutritional Sciences. The secret to her success is rooted in her love for science and pursuing groundbreaking discoveries.
Asked how she copes with the emotional side of her role in palliative care, Abigail Latimer, PhD, MSW, LCSW, puts it simply. “I want to be there for people on some of their hardest days.”
The University of Kentucky College of Medicine is excited to announce that faculty, staff, learners, and trainees will have free access to a leading online resource for medical Spanish proficiency.
CanopyLearn, a Spanish language training program for health care professionals, will be available to the UK College of Medicine community starting Aug. 1.
My name is Panhavuth Phe and I am a recent neuroscience graduate from the UK College of Arts and Sciences and am also a graduate of the Lewis Honors College. I have received departmental honors from the UK College of Medicine Neuroscience Department and was recognized as the “Most Valuable Committee Member” for the 2022 NeuroWeek that was organized by the three UK undergraduate neur
LEXINGTON, Ky. (WKYT) - WKYT is continuing its in-depth look at the work of the Sanders-Brown Center on Aging. The organization, affiliated with the University of Kentucky, employs 125 people. One of them is an RN, and she’s gaining a reputation with her research participants.
A recent study from the lab of the University of Kentucky’s Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., has been published in PLOS ONE. The work centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease (AD). This study focused on a protein known as p38.
(LEX 18) — College students can find themselves on all kinds of interesting trips, but one group from Western Kentucky University is on an all-out adventure.
"We ride, usually, about 70, 75 miles a day and then from there, we get off the bike, get something to eat, go to sleep, wake up and do it all over again," said Trey Englehardt.
Na’Tasha Evans, PhD, MEd, is a researcher, published author, champion for female empowerment, and our new vice dean for diversity, equity, and inclusion at the University of Kentucky College of Medicine. Learn more about her goals, her past work, and more in the following Q&A.
Q: What inspired you to pursue a career in research?
On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease.
Congratulations to the following basic science and clinical faculty at the University of Kentucky College of Medicine! These individuals were honored with promotions and tenure in fiscal year 2023.
Names are organized alphabetically by department.
AnesthesiologySarah Jean Hall, MD, PhD
Associate Professor
A researcher at the University of Kentucky will work to better understand the connection between posttraumatic stress disorder (PTSD) and dementia.
Healthy brain aging is a concern for all of us. June is recognized as Brain and Alzheimer’s Awareness Month. It’s normal to struggle with small things such as recalling names — and we all experience some slowing of the thought processes with advanced age — but everyone hopes to avoid serious cognitive impairment.
“A lot of people who have dementia do not have Alzheimer’s disease.” That is a statement that guides researchers at the University of Kentucky’s Sanders-Brown Center on Aging as they aim to better define other causes of dementia.
Multi-college, collaborative effort explores the underpinnings of cognitive decline
WKYT interviewed a participant in a clinical trial at UK’s Sanders-Brown Center on Aging. For two years, Carol Borkowski took an experimental drug called Lecanemab, a drug for patients with mild symptoms of Alzheimer’s Disease. Her husband, Ron, says during that time Carol stabilized and her symptoms did not get worse.
Following an extensive national search and interviews with highly qualified individuals, the College of Medicine is excited to welcome Na’Tasha Evans, PhD, MEd, as the new vice dean for diversity, equity, and inclusion (DEI) and associate professor in the department of behavioral science.
Samantha Ford had always wanted to go to medical school, but after training in a clinical laboratory setting at the University of Kentucky College of Medicine, she gained a new perspective on how research can play a role in her future career as a physician.